Jet Capital Investors’s Altimmune ALT Stock Holding History

Jet Capital Investors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-7,755	Closed	-$4.21M	–	59
2014 Q4	$4.21M	Hold	7,755	–	–	0.15%	45
2014 Q3	$4.14M	Buy	7,755 +2,969	+62%	+$1.55M	0.15%	42
2014 Q2	$2.02M	Buy	4,786 +1,366	+40%	+$618K	0.09%	39
2014 Q1	$1.88M	Sell	3,420 -666	-16%	-$389K	0.13%	36
2013 Q4	$2.28M	Buy	4,086 +706	+21%	+$421K	0.15%	33
2013 Q3	$2.13M	Buy	+3,380	New	+$1.94M	0.15%	39

Other funds holding ALT

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

GMCM

Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jet Capital Investors's ALT Position: Q1 2015 in Review

Jet Capital Investors sold out of Altimmune (ALT) in Q1 2015, closing a stake of 7,755 shares — an estimated $4.21M sold.

Jet Capital Investors first reported a position in ALT in Q3 2013 and held it in 6 quarters. The position peaked at $4.21M in Q4 2014. 36 funds tracked by Wall St. Rank hold ALT as of Q1 2015.

Jet Capital Investors reported no remaining Altimmune position as of Q1 2015 after selling out during the quarter.
Jet Capital Investors sold 7,755 Altimmune shares in Q1 2015, an estimated $4.21M.
Jet Capital Investors first reported a position in Altimmune in Q3 2013 and held it in 6 quarters.
Jet Capital Investors's Altimmune position peaked at $4.21M in Q4 2014.
36 funds tracked by Wall St. Rank held Altimmune as of Q1 2015.

Based on Jet Capital Investors's 13F filing for Q1 2015, filed 15 May 2015.